Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
AbCellera Biologics
ABCL
$3.36B
| $21.5M | 0.03% |
2,122,403
-858,400
| -29% | -$9.92M |
|
677
ICICI Bank
IBN
$106B
| $21.4M | 0.03% |
979,900
+887,200
| +957% | +$19.8M |
|
678
Vanda Pharmaceuticals
VNDA
$304M
| $21.4M | 0.03% |
2,889,425
-405,808
| -12% | -$3.95M |
|
679
Northern Trust
NTRS
$34.8B
| $21.3M | 0.03% |
+241,098
| New | +$21.1M |
|
680
Booz Allen Hamilton
BAH
$9.43B
| $21.3M | 0.03% |
+203,994
| New | +$21.2M |
|
681
ZipRecruiter
ZIP
$388M
| $21.3M | 0.03% |
1,296,300
+365,900
| +39% | +$6.07M |
|
682
SunCoke Energy
SXC
$788M
| $21.2M | 0.03% |
2,460,068
-353,400
| -13% | -$2.73M |
|
683
Frontline
FRO
$9.02B
| $21.2M | 0.03% |
1,750,842
-2,785,098
| -61% | -$35.8M |
|
684
Utah Medical Products
UTMD
$230M
| $21.2M | 0.03% |
210,614
-5,900
| -3% | -$539K |
|
|
LGTY
685
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $21.2M | 0.03% |
1,441,648
-98,352
| -6% | -$1.51M |
|
686
Orion
OEC
$360M
| $21.1M | 0.03% |
1,185,096
-215,705
| -15% | -$3.63M |
|
687
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $21M | 0.03% |
+201,500
| New | +$20.9M |
|
688
Raymond James Financial
RJF
$34.8B
| $21M | 0.03% |
+196,437
| New | +$22M |
|
689
Southside Bancshares
SBSI
$984M
| $21M | 0.03% |
583,085
-7,100
| -1% | -$252K |
|
690
Agilysys
AGYS
$3.25B
| $20.9M | 0.03% |
264,452
-6,900
| -3% | -$440K |
|
691
Upwork
UPWK
$1.08B
| $20.9M | 0.03% |
1,998,000
+1,355,200
| +211% | +$16.7M |
|
692
Avista
AVA
$3.24B
| $20.8M | 0.03% |
469,422
-29,200
| -6% | -$1.17M |
|
693
Prestige Consumer Healthcare
PBH
$2.43B
| $20.8M | 0.03% |
332,302
-18,400
| -5% | -$1.06M |
|
694
Seaboard Corp
SEB
$4.08B
| $20.7M | 0.03% |
5,496
-503
| -8% | -$1.9M |
|
|
SOHU
695
Sohu.com
SOHU
$364M
| $20.7M | 0.03% |
1,510,755
-138,900
| -8% | -$2.06M |
|
696
Red Rock Resorts
RRR
$3.67B
| $20.6M | 0.03% |
514,300
+185,700
| +57% | +$7.63M |
|
697
Acadia Healthcare
ACHC
$2.82B
| $20.5M | 0.03% |
248,800
+224,500
| +924% | +$18.5M |
|
698
Costamare
CMRE
$1.74B
| $20.5M | 0.03% |
2,206,682
-352,100
| -14% | -$3.31M |
|
699
Iovance Biotherapeutics
IOVA
$2.95B
| $20.5M | 0.03% |
3,200,900
+2,392,300
| +296% | +$18.7M |
|
700
XPO
XPO
$24.7B
| $20.4M | 0.03% |
613,220
-98,049
| -14% | -$3.3M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.